Division of Basic and Translational Research, Department of Surgery, University of Minnesota, Minneapolis, MN 55455, USA.
Department of Experimental and Clinical Pharmacology, University of Minnesota, Minneapolis, MN 55455, USA.
Diagnostics (Basel). 2013 Jan 16;3(1):84-104. doi: 10.3390/diagnostics3010084.
MicroRNAs (miRNAs) are small non-coding RNA molecules, which in recent years have emerged to have enormous potential as biomarkers. Recently, there have been significant developments in understanding miRNA biogenesis, their regulatory mechanisms and role in disease process, and their potential as effective therapies. The identification of miRNAs as biomarkers provides possibilities for development of less or non-invasive and more specific methods for monitoring tumor growth and progression. This review summarizes the recent developments in methods to detect and quantitate miRNAs in body fluids and their applications as biomarkers in cancers. The prospect of miRNAs as potential diagnostic and prognostic biomarkers with clinical applications is significant as more evidence points to their central role in cancer pathobiology.
微小 RNA(miRNA)是一种小型非编码 RNA 分子,近年来作为生物标志物具有巨大的潜力。最近,人们对 miRNA 的生物发生、调控机制及其在疾病过程中的作用,以及作为有效治疗方法的潜力有了更深入的了解。miRNA 作为生物标志物的发现为开发更微创、更特异的方法监测肿瘤生长和进展提供了可能。本文综述了体液中 miRNA 的检测和定量方法的最新进展及其在癌症中作为生物标志物的应用。随着越来越多的证据表明 miRNA 在癌症病理生物学中起核心作用,miRNA 作为有潜在临床应用的诊断和预后生物标志物具有重要意义。